CATX Stock Analysis: Buy, Sell, or Hold?
CATX - Perspective Therapeutics, Inc.
$3.00
0.03 (1.01%)
▲
5d:
+3.09%
30d:
-5.36%
90d:
-16.67%
BUY
MODERATE Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 12, 2026
2d
Get Alerted When CATX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CATX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CATX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CATX is currently trading at $3.00, which is considered slightly low relative to its 30-day fair value range of $2.87 to $3.36.
Technical Outlook: Technically, CATX is in a strong downtrend. Immediate support is located at $2.69, while resistance sits at $3.16.
Market Sentiment: CATX scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.79 (+326.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CATX is in a strong downtrend. Immediate support is located at $2.69, while resistance sits at $3.16.
Market Sentiment: CATX scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.79 (+326.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.87 -
$3.36
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 326.2% below Wall St target ($12.79)
- BULLISH: Bottoming setup score 69/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$2.87 -
$3.36
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.69
Resistance Level
$3.16
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.65
Wall Street Target
$12.79
(+326.2%)
Revenue Growth (YoY)
-77.8%
Share & Embed Analysis
Last updated: August 09, 2026 2:04 AM ET
Data refreshes hourly during market hours. Next update: 3:04 AM
Data refreshes hourly during market hours. Next update: 3:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CATX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 39 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 32 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 41 HOLD |
